Sinopharm Group Co. Ltd.

SHSC:1099 Stock Report

Market Cap: HK$65.2b

Sinopharm Group Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Wanyong Lian

Chief executive officer

CN¥343.6k

Total compensation

CEO salary percentage23.28%
CEO tenure1.3yrs
CEO ownershipn/a
Management average tenure3yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Wanyong Lian's remuneration changed compared to Sinopharm Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

CN¥7b

Jun 30 2025n/an/a

CN¥7b

Mar 31 2025n/an/a

CN¥7b

Dec 31 2024CN¥344kCN¥80k

CN¥7b

Compensation vs Market: Wanyong's total compensation ($USD48.27K) is below average for companies of similar size in the Hong Kong market ($USD868.89K).

Compensation vs Earnings: Insufficient data to compare Wanyong's compensation with company performance.

CEO

Wanyong Lian (54 yo)

1.3yrs
Tenure
CN¥343,640
Compensation

Mr. Wanyong Lian has been the Head of the investment management department of CNPGC since February 2008. Mr. Lian has over 20 years of working experience, all of which is management experience. Mr. Lian wa...

Leadership Team

NamePositionTenureCompensationOwnership
Wanyong Lian
President & Executive Director1.3yrsCN¥343.64kno data
Xiaojuan Li
Chief Financial Officer4.7yrsno datano data
Jinglin Sun
Executive Directorless than a yearno datano data
Yijian Wu
VP, Secretary to the Board & Company Secretary6.9yrsno datano data
3.0yrs
Average Tenure
51.5yo
Average Age

Experienced Management: 1099's management team is considered experienced (3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Wanyong Lian
President & Executive Director1.3yrsCN¥343.64kno data
Jinglin Sun
Executive Directorless than a yearno datano data
Qiyu Chen
Non-Executive Vice Chairman15.5yrsno datano data
Xiaohui Guan
Chief Supervisor4.4yrsno datano data
Yonggang Xing
Non-Executive Directorless than a yearno datano data
Tak Lung Wu
Independent Non-Executive Director5.2yrsCN¥350.00kno data
Peiyu Li
Independent Non-Executive Director5.2yrsCN¥350.00kno data
Bingxiang Zhao
Non-Executive Chairman1.3yrsno datano data
Deyong Wen
Non-Executive Director8.2yrsno datano data
Rongli Feng
Non Executive Director5.4yrsno datano data
Weifeng Yu
Independent Non-Executive Director5.2yrsCN¥350.00kno data
Shenghao Shi
Independent Non-Executive Director2.4yrsCN¥350.00kno data
4.8yrs
Average Tenure
54yo
Average Age

Experienced Board: 1099's board of directors are considered experienced (4.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/11 14:15
End of Day Share Price 2025/11/11 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sinopharm Group Co. Ltd. is covered by 37 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason MannBarclays
Bo LiBofA Global Research
Xiwan JinCCB International Securities Limited